These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31903737)

  • 1. Procoagulant in vitro effects of clinical cellular therapeutics in a severely injured trauma population.
    George MJ; Prabhakara K; Toledano-Furman NE; Gill BS; Wade CE; Cotton BA; Cap AP; Olson SD; Cox CS
    Stem Cells Transl Med; 2020 Apr; 9(4):491-498. PubMed ID: 31903737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Cellular Therapeutics Accelerate Clot Formation.
    George MJ; Prabhakara K; Toledano-Furman NE; Wang YW; Gill BS; Wade CE; Olson SD; Cox CS
    Stem Cells Transl Med; 2018 Oct; 7(10):731-739. PubMed ID: 30070065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procoagulant activity of human mesenchymal stem cells.
    Christy BA; Herzig MC; Montgomery RK; Delavan C; Bynum JA; Reddoch KM; Cap AP
    J Trauma Acute Care Surg; 2017 Jul; 83(1 Suppl 1):S164-S169. PubMed ID: 28628602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy.
    Gleeson BM; Martin K; Ali MT; Kumar AH; Pillai MG; Kumar SP; O'Sullivan JF; Whelan D; Stocca A; Khider W; Barry FP; O'Brien T; Caplice NM
    Stem Cells; 2015 Sep; 33(9):2726-37. PubMed ID: 25969127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients.
    Holcomb JB; Minei KM; Scerbo ML; Radwan ZA; Wade CE; Kozar RA; Gill BS; Albarado R; McNutt MK; Khan S; Adams PR; McCarthy JJ; Cotton BA
    Ann Surg; 2012 Sep; 256(3):476-86. PubMed ID: 22868371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clot Formation Is Associated With Fibrinogen and Platelet Forces in a Cohort of Severely Injured Emergency Department Trauma Patients.
    White NJ; Newton JC; Martin EJ; Mohammed BM; Contaifer D; Bostic JL; Brophy GM; Spiess BD; Pusateri AE; Ward KR; Brophy DF
    Shock; 2015 Aug; 44 Suppl 1(0 1):39-44. PubMed ID: 25643013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight heparin decreases pro-coagulant activity in clinical MSC products.
    Schriner JB; Triolo F; Gill BS; Cardenas JC; Olson SD; Cox CS
    Cytotherapy; 2024 Feb; 26(2):194-200. PubMed ID: 38127031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time.
    Jessen LR; Wiinberg B; Jensen AL; Kjelgaard-Hansen M; Jensen KH; Pedersen LB; Kristensen AT
    Vet Clin Pathol; 2008 Dec; 37(4):363-72. PubMed ID: 19055570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of MSCs and MSC-Derived Extracellular Vesicles on Human Blood Coagulation.
    Silachev DN; Goryunov KV; Shpilyuk MA; Beznoschenko OS; Morozova NY; Kraevaya EE; Popkov VA; Pevzner IB; Zorova LD; Evtushenko EA; Starodubtseva NL; Kononikhin AS; Bugrova AE; Evtushenko EG; Plotnikov EY; Zorov DB; Sukhikh GT
    Cells; 2019 Mar; 8(3):. PubMed ID: 30893822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced cell therapy with low tissue factor loaded product NestaCell® does not confer thrombogenic risk for critically ill COVID-19 heparin-treated patients.
    Araldi RP; Prezoto BC; Gonzaga V; Policiquio B; Mendes TB; D'Amélio F; Vigerelli H; Viana M; Valverde CW; Pagani E; Kerkis I
    Biomed Pharmacother; 2022 May; 149():112920. PubMed ID: 36068779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid thrombelastography delivers real-time results that predict transfusion within 1 hour of admission.
    Cotton BA; Faz G; Hatch QM; Radwan ZA; Podbielski J; Wade C; Kozar RA; Holcomb JB
    J Trauma; 2011 Aug; 71(2):407-14; discussion 414-7. PubMed ID: 21825945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation.
    Zmuda K; Neofotistos D; Ts'ao CH
    Am J Clin Pathol; 2000 May; 113(5):725-31. PubMed ID: 10800406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of dabigatran anticoagulation and its reversal in vitro by thrombelastography.
    Solbeck S; Meyer MA; Johansson PI; Meyer AS; Cotton BA; Stensballe J; Schött U; Ostrowski SR
    Int J Cardiol; 2014 Oct; 176(3):794-9. PubMed ID: 25156858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation for effects of severe acidosis on hemostasis in trauma patients using thrombelastography analyzer.
    Lv X; Mao Y; Qin Z
    Am J Emerg Med; 2018 Aug; 36(8):1332-1340. PubMed ID: 29276028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua.
    Moll G; Ignatowicz L; Catar R; Luecht C; Sadeghi B; Hamad O; Jungebluth P; Dragun D; Schmidtchen A; Ringdén O
    Stem Cells Dev; 2015 Oct; 24(19):2269-79. PubMed ID: 26192403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute traumatic coagulopathy: Whole blood thrombelastography measures the tip of the iceberg.
    Campbell JE; Aden JK; Cap AP
    J Trauma Acute Care Surg; 2015 May; 78(5):955-61. PubMed ID: 25909415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncitrated whole blood is optimal for evaluation of postinjury coagulopathy with point-of-care rapid thrombelastography.
    Kashuk JL; Moore EE; Le T; Lawrence J; Pezold M; Johnson JL; Cothren CC; Biffl WL; Barnett C; Sabel A
    J Surg Res; 2009 Sep; 156(1):133-8. PubMed ID: 19577246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clot activators do not expedite the time to predict massive transfusion in trauma patients analyzed with tissue plasminogen activator thrombelastography.
    Walker CB; Moore EE; Kam A; Dexter-Meldrum J; Nydam TL; Chapman MP; Chandler J; Sauaia A; Barrett CD; Yaffe MB; Moore HB
    Surgery; 2019 Sep; 166(3):408-415. PubMed ID: 31230841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparinase-modified thromboelastography in cats.
    Cuq B; Dunn ME; Bédard C
    J Vet Emerg Crit Care (San Antonio); 2017 Jan; 27(1):127-130. PubMed ID: 28002635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of viscoelastic hemostatic assays and conventional coagulation tests in trauma patients receiving fibrinogen concentrate.
    Peng HT; Nascimento B; Tien H; Callum J; Rizoli S; Rhind SG; Beckett A
    Clin Chim Acta; 2019 Aug; 495():253-262. PubMed ID: 31004574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.